TScan Therapeutics (TCRX) EBIT Margin (QoQ) (2020 - 2026)
TScan Therapeutics (TCRX) EBIT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -203,790.00 |
| Dec 31, 2025 | 54,618.00 |
| Sep 30, 2025 | -21,899.00 |
| Jun 30, 2025 | 41,314.00 |
| Mar 31, 2025 | 385,086.00 |
| Dec 31, 2024 | -241,078.00 |
| Sep 30, 2024 | 325,473.00 |
| Jun 30, 2024 | -82,162.00 |
| Mar 31, 2024 | -524,676.00 |
| Dec 31, 2023 | 34,051.00 |
| Sep 30, 2023 | 14,508.00 |
| Jun 30, 2023 | -38,965.00 |
| Mar 31, 2023 | 21,043.00 |
| Dec 31, 2022 | -10,960.00 |
| Sep 30, 2022 | -11,707.00 |
| Jun 30, 2022 | 15,913.00 |
| Mar 31, 2022 | -3,740.00 |
| Dec 31, 2021 | 15,918.00 |
| Sep 30, 2021 | -28,183.00 |
| Jun 30, 2021 | 1,566.00 |